"Additional risk factors are a personal history of Breast or ovarian cancer, age (over age 40), and a family history of uterine cancer."
As she reports in the American Journal of Epidemiology, among those who used ovulation-inducing drugs the risk of developing uterine cancer was three times that of untreated women.
But at least where uterine cancer is concerned, she says, follow-up studies and screening should be considered for women taking such drugs.
Objective To understand the clinical application of cisplatin internal iliac artery infusion for uterine cancer treatment.
Raloxifene prevents breast cancer and does not increase the risk of uterine cancer, she added.
Tamoxifen can result in serious side effects including blood clots, strokes, uterine cancer and cataracts.
"Whites are more likely to develop uterine cancer than are blacks. The major symptom is vaginal bleeding or discharge. Treatment may begin with simple or radical hysterectomy. Some uterine cancers are treated in part by hormonal therapy, radiation therapy, or chemotherapy. "
But while tamoxifen has been associated with side effects including an increased risk of uterine cancer, preliminary studies of raloxifene suggest it doesn't pose the same risk.
